These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32621976)

  • 1. Skin sensitization in silico protocol.
    Johnson C; Ahlberg E; Anger LT; Beilke L; Benigni R; Bercu J; Bobst S; Bower D; Brigo A; Campbell S; Cronin MTD; Crooks I; Cross KP; Doktorova T; Exner T; Faulkner D; Fearon IM; Fehr M; Gad SC; Gervais V; Giddings A; Glowienke S; Hardy B; Hasselgren C; Hillegass J; Jolly R; Krupp E; Lomnitski L; Magby J; Mestres J; Milchak L; Miller S; Muster W; Neilson L; Parakhia R; Parenty A; Parris P; Paulino A; Paulino AT; Roberts DW; Schlecker H; Stidl R; Suarez-Rodrigez D; Szabo DT; Tice RR; Urbisch D; Vuorinen A; Wall B; Weiler T; White AT; Whritenour J; Wichard J; Woolley D; Zwickl C; Myatt GJ
    Regul Toxicol Pharmacol; 2020 Oct; 116():104688. PubMed ID: 32621976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational approaches for skin sensitization prediction.
    Wilm A; Kühnl J; Kirchmair J
    Crit Rev Toxicol; 2018 Oct; 48(9):738-760. PubMed ID: 30488745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the art in non-animal approaches for skin sensitization testing: from individual test methods towards testing strategies.
    Ezendam J; Braakhuis HM; Vandebriel RJ
    Arch Toxicol; 2016 Dec; 90(12):2861-2883. PubMed ID: 27629427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
    Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M
    Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of a defined approach based on a stacking prediction model to identify skin sensitization hazard.
    Tourneix F; Alépée N; Detroyer A; Eilstein J; Martinozzi Teissier S; Nardelli L; Noçairi H; Pauloin T; Piroird C; Del Bufalo A
    Toxicol In Vitro; 2019 Oct; 60():134-143. PubMed ID: 31100378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Applicability of an Integrated Testing Strategy consisting of in silico, in chemico and in vitro assays for evaluating the skin sensitization potencies of isocyanates.
    Ohtake T; Maeda Y; Hayashi T; Yamanaka H; Nakai M; Takeyoshi M
    Toxicology; 2018 Jan; 393():9-14. PubMed ID: 29100879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards AOP application--implementation of an integrated approach to testing and assessment (IATA) into a pipeline tool for skin sensitization.
    Patlewicz G; Kuseva C; Kesova A; Popova I; Zhechev T; Pavlov T; Roberts DW; Mekenyan O
    Regul Toxicol Pharmacol; 2014 Aug; 69(3):529-45. PubMed ID: 24928565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computer models versus reality: how well do in silico models currently predict the sensitization potential of a substance.
    Teubner W; Mehling A; Schuster PX; Guth K; Worth A; Burton J; van Ravenzwaay B; Landsiedel R
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):468-85. PubMed ID: 24090701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A defined approach for predicting skin sensitisation hazard and potency based on the guided integration of in silico, in chemico and in vitro data using exclusion criteria.
    Macmillan DS; Chilton ML
    Regul Toxicol Pharmacol; 2019 Feb; 101():35-47. PubMed ID: 30439387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 21st Century movement within the area of skin sensitization assessment: From the animal context towards current human-relevant in vitro solutions.
    de Ávila RI; Lindstedt M; Valadares MC
    Regul Toxicol Pharmacol; 2019 Nov; 108():104445. PubMed ID: 31430506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro skin sensitization assay termed EpiSensA for broad sets of chemicals including lipophilic chemicals and pre/pro-haptens.
    Saito K; Takenouchi O; Nukada Y; Miyazawa M; Sakaguchi H
    Toxicol In Vitro; 2017 Apr; 40():11-25. PubMed ID: 27965148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a new in vitro skin sensitization assay (Epidermal Sensitization Assay; EpiSensA) using reconstructed human epidermis.
    Saito K; Nukada Y; Takenouchi O; Miyazawa M; Sakaguchi H; Nishiyama N
    Toxicol In Vitro; 2013 Dec; 27(8):2213-24. PubMed ID: 23999411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic toxicology in silico protocol.
    Hasselgren C; Ahlberg E; Akahori Y; Amberg A; Anger LT; Atienzar F; Auerbach S; Beilke L; Bellion P; Benigni R; Bercu J; Booth ED; Bower D; Brigo A; Cammerer Z; Cronin MTD; Crooks I; Cross KP; Custer L; Dobo K; Doktorova T; Faulkner D; Ford KA; Fortin MC; Frericks M; Gad-McDonald SE; Gellatly N; Gerets H; Gervais V; Glowienke S; Van Gompel J; Harvey JS; Hillegass J; Honma M; Hsieh JH; Hsu CW; Barton-Maclaren TS; Johnson C; Jolly R; Jones D; Kemper R; Kenyon MO; Kruhlak NL; Kulkarni SA; Kümmerer K; Leavitt P; Masten S; Miller S; Moudgal C; Muster W; Paulino A; Lo Piparo E; Powley M; Quigley DP; Reddy MV; Richarz AN; Schilter B; Snyder RD; Stavitskaya L; Stidl R; Szabo DT; Teasdale A; Tice RR; Trejo-Martin A; Vuorinen A; Wall BA; Watts P; White AT; Wichard J; Witt KL; Woolley A; Woolley D; Zwickl C; Myatt GJ
    Regul Toxicol Pharmacol; 2019 Oct; 107():104403. PubMed ID: 31195068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of IATA - A case study in evaluating the global and local performance of a Bayesian network model for skin sensitization.
    Fitzpatrick JM; Patlewicz G
    SAR QSAR Environ Res; 2017 Apr; 28(4):297-310. PubMed ID: 28423913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An in vitro human skin test for assessing sensitization potential.
    Ahmed SS; Wang XN; Fielding M; Kerry A; Dickinson I; Munuswamy R; Kimber I; Dickinson AM
    J Appl Toxicol; 2016 May; 36(5):669-84. PubMed ID: 26251951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte surface markers and cytokines are suitable for detection and potency assessment of skin-sensitizing chemicals in an in vitro model of allergic contact dermatitis: the LCSA-ly.
    Frombach J; Sonnenburg A; Krapohl BD; Zuberbier T; Peiser M; Stahlmann R; Schreiner M
    Arch Toxicol; 2018 Apr; 92(4):1495-1505. PubMed ID: 29380012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic understanding of dendritic cell activation in skin sensitization: additional evidences to support potency classification.
    Galbiati V; Marinovich M; Corsini E
    Toxicol Lett; 2020 Apr; 322():50-57. PubMed ID: 31958493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergic contact dermatitis--formation, structural requirements, and reactivity of skin sensitizers.
    Karlberg AT; Bergström MA; Börje A; Luthman K; Nilsson JL
    Chem Res Toxicol; 2008 Jan; 21(1):53-69. PubMed ID: 18052130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A data-based exploration of the adverse outcome pathway for skin sensitization points to the necessary requirements for its prediction with alternative methods.
    Benigni R; Bossa C; Tcheremenskaia O
    Regul Toxicol Pharmacol; 2016 Jul; 78():45-52. PubMed ID: 27090483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pre- and pro-haptens with a β-galactosidase-expressing E. coli culture system for skin sensitization.
    Nepal MR; Kang MJ; Kim GH; Cha DH; Nam DH; Jeong TC
    Toxicol Lett; 2019 May; 305():81-93. PubMed ID: 30711672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.